Cargando…
Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status
The estrogen receptor (ER) α is overexpressed in most breast cancers, and its level serves as a major prognostic factor. It is important to develop quantitative molecular imaging methods that specifically detect ER in vivo and assess its function throughout the entire primary breast cancer and in me...
Autores principales: | Pais, Adi, Degani, Hadassa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846659/ https://www.ncbi.nlm.nih.gov/pubmed/27200289 http://dx.doi.org/10.3389/fonc.2016.00100 |
Ejemplares similares
-
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
por: Nissan, Noam, et al.
Publicado: (2014) -
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022) -
Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
por: Caldon, C. Elizabeth
Publicado: (2014) -
Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
por: Feng, Shuqian, et al.
Publicado: (2022) -
Prediction Breast Molecular Typing of Invasive Ductal Carcinoma Based on Dynamic Contrast Enhancement Magnetic Resonance Imaging Radiomics Characteristics: A Feasibility Study
por: Xu, Aqiao, et al.
Publicado: (2022)